Dr. Keren is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
# 2
Ann Arbor, MI 48109Phone+1 800-862-7284
Education & Training
- Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 1971 - 1976
- University of Illinois College of MedicineClass of 1971
Certifications & Licensure
- MI State Medical License 1978 - 2026
- MD State Medical License 1973 - 1978
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Immunopathology
Publications & Presentations
PubMed
- Mystery Solved: Acquired Hemoglobin After Red Cell Exchange on Sickle Cell Patient.Nada Naiyer, David Keren, Chisa Yamada
Journal of Clinical Apheresis. 2024-12-01 - 1 citationsChatGPT vs Medical Professional: Analyzing Responses to Laboratory Medicine Questions on Social Media.Mark R Girton, Dina N Greene, Geralyn Messerlian, David F Keren, Min Yu
Clinical Chemistry. 2024-09-03 - Retrospective analysis of serum free light chain reference intervals and risk for monoclonal gammopathy suggests different limits than those in international guidelines.Lee F Schroeder, David M Manthei, David F Keren
Clinical Biochemistry. 2023-08-01
Journal Articles
- Effect of Diabetes Mellitus on Sickle Hemoglobin Quantitation in Sickle Cell TraitDavid F Keren, Lee F Schroeder, American Journal of Clinical Pathology
Press Mentions
- Core Lab Efficiencies in Monoclonal Gammopathy TestingMay 21st, 2024
- College of American Pathologists Honors 31 Members/Residents at CAP21 Annual MeetingSeptember 26th, 2021
- New CAP Guideline Improves Diagnoses of Patients with Monoclonal GammopathiesAugust 10th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: